Search results
Electric Up-And Comer Lucid's Stock 'Still In Park': Analysts Expect Investors To Keep 'Conservative...
Benzinga via Yahoo Finance· 6 hours agoThe Lucid Analysts: Stifel analyst Stephen Gengaro has a Hold rating and $4 price target on Lucid....
Lucid Stock Drops After Earnings. Saudi Help Isn’t Helping.
Barrons.com· 14 hours agoThe company’s first-quarter sales were better than expected, but a big portion of sales came from a...
Lucid stock down on Q1 loss, confirms Gravity SUV on track for 'late 2024' launch
Yahoo Finance via AOL· 14 hours agoEV maker Lucid reported mixed first quarter results as a wider-than-expected loss trumped the...
Lucid's Upcoming Midsize Car Targets $48,000 Price, CEO Says
InsideEVs· 8 hours agoLucid Motors' upcoming midsized vehicle will cost about the same as a Tesla Model Y Long Range, the...
What to do with Lucid stock after earnings? Analysts answer By Investing.com
Investing.com· 13 hours agoFor investors eyeing Lucid stock, the post-earnings landscape presents a crucial juncture. With...
Lucid Group, Inc. (NASDAQ:LCID) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 13 hours agoLucid Group, Inc. (NASDAQ:LCID) Q1 2024 Earnings Call Transcript May 6, 2024 Lucid Group, Inc....
Smart Investors Will Steer Clear of Rivian Stock Even if It Rallies After Earnings
InvestorPlace· 10 hours agoRivian Automotive (NASDAQ:RIVN) is the next electric vehicle manufacturer to report quarterly...
Earnings call: Lucid Group Q1 2024 earnings highlight growth and expansion By Investing.com
Investing.com· 11 hours agoThe electric vehicle maker raised $1 billion in capital through a private placement of convertible...
Lucid Group earnings missed by $0.05, revenue fell short of estimates By Investing.com
Investing.com· 1 day agoLucid Group earnings missed by $0.05, revenue fell short of estimates
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry...
FOX 4 Kansas City· 16 hours agoLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary ...